机构:[a]School of Pharmaceutical Sciences, Guangdong Key Laboratory for Genome Stability & Human Disease Prevention, Shenzhen Key Laboratory of Novel Natural Health Care Products, Innovation Platform for Natural small molecule Drugs, Engineering Laboratory of Shenzhen Natural small molecule Innovative Drugs, Shenzhen University, Shenzhen, 518060, China[b]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China四川大学华西医院[c]Institute of Traditional Chinese Medicine & Natural Products, and Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, 510632, China[d]Shenzhen Honghui Bio-Pharmaceutical Co. Ltd., Shenzhen, 518118, China[e]College of Pharmacy, Harbin Medical University, Harbin, 150081, China
This work was received the supported of Key Projects of the
National Science and Technology Major Projects for New Drug
Development (2018ZX097350052), The National Key R & D Program of
China (2017YFA0503900), National Natural Science Foundation of
China (31670360, 81803365 and U1702286) and Post-Doctor Research
Project (2018M643510, 2019M650213).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类|2 区医学
小类|2 区药学
最新[2023]版:
大类|2 区医学
小类|1 区药学
第一作者:
第一作者机构:[a]School of Pharmaceutical Sciences, Guangdong Key Laboratory for Genome Stability & Human Disease Prevention, Shenzhen Key Laboratory of Novel Natural Health Care Products, Innovation Platform for Natural small molecule Drugs, Engineering Laboratory of Shenzhen Natural small molecule Innovative Drugs, Shenzhen University, Shenzhen, 518060, China
通讯作者:
通讯机构:[d]Shenzhen Honghui Bio-Pharmaceutical Co. Ltd., Shenzhen, 518118, China[e]College of Pharmacy, Harbin Medical University, Harbin, 150081, China[*1]Shenzhen Honghui Bio-Pharmaceutical Co. Ltd., Shenzhen, 518118, China
推荐引用方式(GB/T 7714):
Dahong Yao,Dabo Pan,Yongqi Zhen,et al.Ferulin C triggers potent PAK1 and p21-mediated anti-tumor effects in breast cancer by inhibiting Tubulin polymerization in vitro and in vivo.[J].Pharmacological research.2020,152:104605.doi:10.1016/j.phrs.2019.104605.
APA:
Dahong Yao,Dabo Pan,Yongqi Zhen,Jian Huang,Jinhui Wang...&Zhendan He.(2020).Ferulin C triggers potent PAK1 and p21-mediated anti-tumor effects in breast cancer by inhibiting Tubulin polymerization in vitro and in vivo..Pharmacological research,152,
MLA:
Dahong Yao,et al."Ferulin C triggers potent PAK1 and p21-mediated anti-tumor effects in breast cancer by inhibiting Tubulin polymerization in vitro and in vivo.".Pharmacological research 152.(2020):104605